Cargando…

Metabolic profiling of Parkinson's disease: evidence of biomarker from gene expression analysis and rapid neural network detection

BACKGROUND: Parkinson's disease (PD) is a neurodegenerative disorder. The diagnosis of Parkinsonism is challenging because currently none of the clinical tests have been proven to help in diagnosis. PD may produce characteristic perturbations in the metabolome and such variations can be used as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Shiek SSJ, Santosh, Winkins, Kumar, Suresh, Christlet, Hema T Thanka
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720938/ https://www.ncbi.nlm.nih.gov/pubmed/19594911 http://dx.doi.org/10.1186/1423-0127-16-63

Ejemplares similares

Systems biological approach on neurological disorders: a novel molecular connectivity to aging and psychiatric diseases
por: Ahmed, Shiek SSJ, et al.
Publicado: (2011)

Polycaprolactone scaffold engineered for sustained release of resveratrol: therapeutic enhancement in bone tissue engineering
por: Kamath, Manjunath Srinivas, et al.
Publicado: (2013)

Metallomic Profiling and Linkage Map Analysis of Early Parkinson's Disease: A New Insight to Aluminum Marker for the Possible Diagnosis
por: Ahmed, Shiek S. S. J., et al.
Publicado: (2010)

Relevance of systems biological approach in the differential diagnosis of invasive lobular carcinoma & invasive ductal carcinoma
por: Ragunath, PK, et al.
Publicado: (2012)

Metallomic Biomarkers in Cerebrospinal fluid and Serum in patients with Parkinson’s disease in Indian population
por: Sanyal, Jaya, et al.
Publicado: (2016)

Multi-target potential of Indian phytochemicals against SARS-CoV-2: A docking, molecular dynamics and MM-GBSA approach extended to Omicron B.1.1.529.
por: Roshni, Jency, et al.
Publicado: (2022)

The neural substrates of Rapid-Onset Dystonia-Parkinsonism
por: Calderon, D. Paola, et al.
Publicado: (2011)

Screening of Crucial Cytosolicproteins Interconnecting the Endoplasmic Reticulum and Mitochondria in Parkinson’s Disease and the Impact of Anti-Parkinson Drugs in the Preservation of Organelle Connectivity
por: Anirudhan, Athira, et al.
Publicado: (2023)

A metabolic profile of polyamines in parkinson disease: A promising biomarker
por: Saiki, Shinji, et al.
Publicado: (2019)

Interdependence of metals and its binding proteins in Parkinson’s disease for diagnosis
por: Anirudhan, Athira, et al.
Publicado: (2021)

Biopsable Neural Tissues: Toward New Biomarkers for Parkinson's Disease?
por: Lebouvier, Thibaud, et al.
Publicado: (2010)

Gene Regulatory Networks in Peripheral Mononuclear Cells Reveals Critical Regulatory Modules and Regulators of Multiple Sclerosis
por: Gnanakkumaar, Perumal, et al.
Publicado: (2019)

Biomarker Research in Parkinson’s Disease Using Metabolite Profiling
por: Havelund, Jesper F., et al.
Publicado: (2017)

RPL6: A Key Molecule Regulating Zinc- and Magnesium-Bound Metalloproteins of Parkinson’s Disease
por: Anirudhan, Athira, et al.
Publicado: (2021)

Deep neural network for discovering metabolism-related biomarkers for lung adenocarcinoma
por: Fu, Lei, et al.
Publicado: (2023)

Rapid Recalibration of Peri-Personal Space: Psychophysical, Electrophysiological, and Neural Network Modeling Evidence
por: Noel, Jean-Paul, et al.
Publicado: (2020)

Speech Biomarkers in Rapid Eye Movement Sleep Behavior Disorder and Parkinson Disease
por: Rusz, Jan, et al.
Publicado: (2021)

Rapid motor fluctuations reveal short-timescale neurophysiological biomarkers of Parkinson’s disease
por: Ahn, Minkyu, et al.
Publicado: (2020)

Expression of Matrix Metalloproteinase-9 in Gastric Cancer
por: R, Prathipaa, et al.
Publicado: (2021)

A Case of Multiple Plexiform Schwannomas
por: Bhaumik, Somdatta, et al.
Publicado: (2022)

Expression of Vascular Endothelial Growth Factor (VEGF) in Colorectal Adenoma and Carcinoma in a Tertiary Care Center
por: Balasubramanian, Subalakshmi, et al.
Publicado: (2022)

Systems Biological Approach of Molecular Descriptors Connectivity: Optimal Descriptors for Oral Bioavailability Prediction
por: Ahmed, Shiek S. S. J., et al.
Publicado: (2012)

metabolic profiling of Parkinson's disease and mild cognitive impairment
por: Burté, Florence, et al.
Publicado: (2017)

YKL-40 and the Cellular Metabolic Profile in Parkinson’s Disease
por: Gevezova, Maria, et al.
Publicado: (2023)

Clinical utility of brain-derived neurotrophic factor as a biomarker with left ventricular echocardiographic indices for potential diagnosis of coronary artery disease
por: Monisha, K. G., et al.
Publicado: (2020)

Neural and behavioral substrates of subtypes of Parkinson’s disease
por: Moustafa, Ahmed A., et al.
Publicado: (2013)

Double Pathology: Malignant Epithelial Ovarian Tumor and Germ Cell Tumor (Choriocarcinoma), a Rare Coexistence
por: Shanmugasundaram, Gouthaman, et al.
Publicado: (2015)

The Role of Neural Network for the Detection of Parkinson’s Disease: A Scoping Review
por: Alzubaidi, Mahmood Saleh, et al.
Publicado: (2021)

Biocompatibility evaluation of sputtered zirconium-based thin film metallic glass-coated steels
por: Subramanian, Balasubramanian, et al.
Publicado: (2015)

Metabolic Profiling of Serum for Osteoarthritis Biomarkers
por: Xiao, Ziqian, et al.
Publicado: (2022)

Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s disease
por: Karayel, Ozge, et al.
Publicado: (2022)

Cytokine profiles of plasma extracellular vesicles as progression biomarkers in Parkinson’s disease
por: Chan, Lung, et al.
Publicado: (2023)

Patterns of Longitudinal Neural Activity Linked to Different Cognitive Profiles in Parkinson's Disease
por: Nagano-Saito, Atsuko, et al.
Publicado: (2016)

Alpha-synuclein as a biomarker in Parkinson's disease: focus on neural derived extracelluar vesicles
por: Agliardi, Cristina, et al.
Publicado: (2021)

Parkinson’s disease dementia: a neural networks perspective
por: Gratwicke, James, et al.
Publicado: (2015)

Graph Neural Networks for Parkinson’s Disease Monitoring and Alerting
por: Zafeiropoulos, Nikolaos, et al.
Publicado: (2023)

Solitary Dermal Cylindroma in an Uncommon Site: A Rare Case Report
por: V., Lakshmi Priya, et al.
Publicado: (2022)

Metabolic network as an objective biomarker in monitoring deep brain stimulation for Parkinson’s disease: a longitudinal study
por: Ge, Jingjie, et al.
Publicado: (2020)

Gene Expression Profiling Combined with Bioinformatics Analysis Identify Biomarkers for Parkinson Disease
por: Diao, Hongyu, et al.
Publicado: (2012)

Comprehensive metabolic profiling of Parkinson’s disease by liquid chromatography-mass spectrometry
por: Shao, Yaping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sodlns672dp6qkevc51vhe7tac